Results
|
|
1.
|
The experience of immune checkpoint inhibitors in Chinese patients with metastatic melanoma: a retrospective case series. [electronic resource] by
- Wen, Xizhi
- Ding, Ya
- Li, Jingjing
- Zhao, Jingjing
- Peng, Ruiqing
- Li, Dandan
- Zhu, Baoyan
- Wang, Yao
- Zhang, Xing
- Zhang, Xiaoshi
Producer: 20180108
In:
Cancer immunology, immunotherapy : CII vol. 66
Availability: No items available.
|
|
|
2.
|
A favorable outcome of advanced dermatofibrosarcoma protuberans under treatment with sunitinib after imatinib failure. [electronic resource] by
- Xiao, Wei
- Que, Yi
- Peng, Ruiqing
- Ding, Ya
- Zhao, Jingjing
- Wen, Xizhi
- Weng, Desheng
- Zhang, Xiaoshi
- Guan, Yuanxiang
- Zhang, Xing
Publication details: OncoTargets and therapy 2018
In:
OncoTargets and therapy vol. 11
Availability: No items available.
|
|
|
3.
|
Time-varying pattern of recurrence risk for localized melanoma in China. [electronic resource] by
- Wen, Xizhi
- Li, Dandan
- Zhao, Jingjing
- Li, Jingjing
- Yang, Tao
- Ding, Ya
- Peng, Ruiqing
- Zhu, Baoyan
- Huang, Fuxue
- Zhang, Xiaoshi
Producer: 20200722
In:
World journal of surgical oncology vol. 18
Availability: No items available.
|
|
|
4.
|
Comparison of the MAID (AI) and CAV/IE regimens with the predictive value of cyclic AMP-responsive element-binding protein 3 like protein 1 (CREB3L1) in palliative chemotherapy for advanced soft-tissue sarcoma patients. [electronic resource] by
- Xiao, Wei
- Liang, Yao
- Que, Yi
- Li, Jingjing
- Peng, Ruiqing
- Xu, Bushu
- Wen, Xizhi
- Zhao, Jingjing
- Guan, Yuanxiang
- Zhang, Xing
Publication details: Journal of Cancer 2019
In:
Journal of Cancer vol. 10
Availability: No items available.
|
|
|
5.
|
Safety of immune checkpoint inhibitors in Chinese patients with melanoma. [electronic resource] by
- Wen, Xizhi
- Wang, Yao
- Ding, Ya
- Li, Dandan
- Li, Jingjing
- Guo, Yiqun
- Peng, Ruiqing
- Zhao, Jingjing
- Zhang, Xing
- Zhang, Xiao-Shi
Producer: 20180117
In:
Melanoma research vol. 26
Availability: No items available.
|
|
|
6.
|
Chimeric antigen receptor-modified T-cell therapy for platelet-derived growth factor receptor α-positive rhabdomyosarcoma. [electronic resource] by
- Xiao, Wei
- Wang, Jinghua
- Wen, Xizhi
- Xu, Bushu
- Que, Yi
- Yu, Kuai
- Xu, Liping
- Zhao, Jingjing
- Pan, Qiuzhong
- Zhou, Penghui
- Zhang, Xing
Producer: 20220504
In:
Cancer vol. 126 Suppl 9
Availability: No items available.
|
|
|
7.
|
Cryoablation combined with transarterial infusion of pembrolizumab (CATAP) for liver metastases of melanoma: an ambispective, proof-of-concept cohort study. [electronic resource] by
- Shen, Lujun
- Qi, Han
- Chen, Shuanggang
- Cao, Fei
- Xie, Lin
- Wu, Ying
- Ma, Weimei
- Song, Ze
- Yuan, Hui
- Zhang, Tao
- Li, Dandan
- Wen, Xizhi
- Chen, Qifeng
- Li, Wang
- Zhang, Xiaoshi
- Fan, Weijun
Producer: 20200817
In:
Cancer immunology, immunotherapy : CII vol. 69
Availability: No items available.
|
|
|
8.
|
A Phase Ib Study of Pembrolizumab as Second-Line Therapy for Chinese Patients With Advanced or Metastatic Melanoma (KEYNOTE-151). [electronic resource] by
- Si, Lu
- Zhang, Xiaoshi
- Shu, Yongqian
- Pan, Hongming
- Wu, Di
- Liu, Jiwei
- Lou, Fang
- Mao, Lili
- Wang, Xuan
- Wen, Xizhi
- Gu, Yanhong
- Zhu, Lingjun
- Lan, Shijie
- Cai, Xin
- Diede, Scott J
- Zhou, Yu
- Ge, Jun
- Li, Jianfeng
- Wu, Haiyan
- Guo, Jun
Publication details: Translational oncology Jun 2019
In:
Translational oncology vol. 12
Availability: No items available.
|
|
|
9.
|
The DNA Methylcytosine Dioxygenase Tet2 Sustains Immunosuppressive Function of Tumor-Infiltrating Myeloid Cells to Promote Melanoma Progression. [electronic resource] by
- Pan, Wen
- Zhu, Shu
- Qu, Kun
- Meeth, Katrina
- Cheng, Jijun
- He, Kaixin
- Ma, Hongdi
- Liao, Yan
- Wen, Xizhi
- Roden, Christine
- Tobiasova, Zuzana
- Wei, Zheng
- Zhao, Jun
- Liu, Jun
- Zheng, Ji
- Guo, Bo
- Khan, Sajid A
- Bosenberg, Marcus
- Flavell, Richard A
- Lu, Jun
Producer: 20170928
In:
Immunity vol. 47
Availability: No items available.
|